188 related articles for article (PubMed ID: 22832710)
1. Next-generation sequencing to assess HIV tropism.
Swenson LC; Däumer M; Paredes R
Curr Opin HIV AIDS; 2012 Sep; 7(5):478-85. PubMed ID: 22832710
[TBL] [Abstract][Full Text] [Related]
2. HIV population genotypic tropism testing and its clinical significance.
Obermeier M; Symons J; Wensing AM
Curr Opin HIV AIDS; 2012 Sep; 7(5):470-7. PubMed ID: 22832711
[TBL] [Abstract][Full Text] [Related]
3. Phenotyping methods for determining HIV tropism and applications in clinical settings.
Raymond S; Delobel P; Izopet J
Curr Opin HIV AIDS; 2012 Sep; 7(5):463-9. PubMed ID: 22832712
[TBL] [Abstract][Full Text] [Related]
4. Use of cellular HIV DNA to predict virologic response to maraviroc: performance of population-based and deep sequencing.
Swenson LC; Dong WW; Mo T; Demarest J; Chapman D; Ellery S; Heera J; Valdez H; Poon AF; Harrigan PR
Clin Infect Dis; 2013 Jun; 56(11):1659-66. PubMed ID: 23429552
[TBL] [Abstract][Full Text] [Related]
5. Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients.
Swenson LC; Mo T; Dong WW; Zhong X; Woods CK; Jensen MA; Thielen A; Chapman D; Lewis M; James I; Heera J; Valdez H; Harrigan PR
J Infect Dis; 2011 Jan; 203(2):237-45. PubMed ID: 21288824
[TBL] [Abstract][Full Text] [Related]
6. Deep V3 sequencing for HIV type 1 tropism in treatment-naive patients: a reanalysis of the MERIT trial of maraviroc.
Swenson LC; Mo T; Dong WW; Zhong X; Woods CK; Thielen A; Jensen MA; Knapp DJ; Chapman D; Portsmouth S; Lewis M; James I; Heera J; Valdez H; Harrigan PR
Clin Infect Dis; 2011 Oct; 53(7):732-42. PubMed ID: 21890778
[TBL] [Abstract][Full Text] [Related]
7. Correlation between genotypic (V3 population sequencing) and phenotypic (Trofile ES) methods of characterizing co-receptor usage of HIV-1 from 200 treatment-naïve HIV patients screened for Study A4001078.
Portsmouth S; Valluri SR; Däumer M; Thiele B; Valdez H; Lewis M; Craig C; Thielen A; James I; Demarest J; Heera J
Antiviral Res; 2013 Jan; 97(1):60-5. PubMed ID: 23165088
[TBL] [Abstract][Full Text] [Related]
8. [HIV tropism assays when first CCR5-antagonist becomes available].
Soulié C; Calvez V
Med Mal Infect; 2008 Mar; 38 Suppl 1():S7-11. PubMed ID: 18455056
[TBL] [Abstract][Full Text] [Related]
9. Performance of a clonal-based HIV-1 tropism phenotypic assay.
Asin-Milan O; Wei Y; Sylla M; Vaisheva F; Chamberland A; Tremblay CL
J Virol Methods; 2014 Aug; 204():53-61. PubMed ID: 24731927
[TBL] [Abstract][Full Text] [Related]
10. Improvement of HIV-1 coreceptor tropism prediction by employing selected nucleotide positions of the env gene in a Bayesian network classifier.
Díez-Fuertes F; Delgado E; Vega Y; Fernández-García A; Cuevas MT; Pinilla M; García V; Pérez-Álvarez L; Thomson MM
J Antimicrob Chemother; 2013 Jul; 68(7):1471-85. PubMed ID: 23511232
[TBL] [Abstract][Full Text] [Related]
11. Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR5 antagonists.
Poveda E; Seclén E; González Mdel M; García F; Chueca N; Aguilera A; Rodríguez JJ; González-Lahoz J; Soriano V
J Antimicrob Chemother; 2009 May; 63(5):1006-10. PubMed ID: 19261623
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool.
Visseaux B; Hurtado-Nedelec M; Charpentier C; Collin G; Storto A; Matheron S; Larrouy L; Damond F; Brun-Vézinet F; Descamps D;
J Infect Dis; 2012 Jan; 205(1):111-20. PubMed ID: 22140264
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of genotypic prediction of HIV-1 tropism using population sequencing of replicates.
Ferreira JL; Coelho LP; Rodrigues R; Cabral GB; Cavalcanti Jde S; Guimaraes PM; Brigido LF
J Virol Methods; 2012 Feb; 179(2):325-9. PubMed ID: 22138669
[TBL] [Abstract][Full Text] [Related]
14. Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice.
Symons J; Vandekerckhove L; Paredes R; Verhofstede C; Bellido R; Demecheleer E; van Ham PM; van Lelyveld SF; Stam AJ; van Versendaal D; Nijhuis M; Wensing AM
Clin Microbiol Infect; 2012 Jun; 18(6):606-12. PubMed ID: 21906210
[TBL] [Abstract][Full Text] [Related]
15. Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group.
Svicher V; Alteri C; Montano M; D'Arrigo R; Andreoni M; Angarano G; Antinori A; Antonelli G; Allice T; Bagnarelli P; Baldanti F; Bertoli A; Borderi M; Boeri E; Bon I; Bruzzone B; Callegaro AP; Capobianchi MR; Carosi G; Cauda R; Ceccherini-Silberstein F; Clementi M; Chirianni A; Colafigli M; D'Arminio Monforte A; De Luca A; Di Biagio A; Di Nicuolo G; Di Perri G; Di Pietro M; Di Santo F; Fabeni L; Fadda G; Galli M; Gennari W; Ghisetti V; Giacometti A; Gori C; Gori A; Gulminetti R; Leoncini F; Maffongelli G; Maggiolo F; Manca G; Gargiulo F; Martinelli C; Maserati R; Mazzotta F; Meini G; Micheli V; Monno L; Mussini C; Narciso P; Nozza S; Paolucci S; Pal G; Parisi S; Parruti G; Pignataro AR; Pollicita M; Quirino T; Re MC; Rizzardini G; Santangelo R; Scaggiante R; Sterrantino G; Turriziani O; Vatteroni ML; Vecchi L; Viscoli C; Vullo V; Zazzi M; Lazzarini A; Perno CF;
New Microbiol; 2012 Jan; 35(1):17-25. PubMed ID: 22378549
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of HIV coreceptor tropism.
Hoffmann C
Eur J Med Res; 2007 Oct; 12(9):385-90. PubMed ID: 17933718
[TBL] [Abstract][Full Text] [Related]
17. Performance assessment of the Illumina massively parallel sequencing platform for deep sequencing analysis of viral minority variants.
Thys K; Verhasselt P; Reumers J; Verbist BM; Maes B; Aerssens J
J Virol Methods; 2015 Sep; 221():29-38. PubMed ID: 25917877
[TBL] [Abstract][Full Text] [Related]
18. Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use.
Raymond S; Nicot F; Jeanne N; Delfour O; Carcenac R; Lefebvre C; Cazabat M; Sauné K; Delobel P; Izopet J
Sci Rep; 2017 Feb; 7():42215. PubMed ID: 28186189
[TBL] [Abstract][Full Text] [Related]
19. Development and performance of a new recombinant virus phenotypic entry assay to determine HIV-1 coreceptor usage.
Raymond S; Delobel P; Mavigner M; Cazabat M; Souyris C; Encinas S; Bruel P; Sandres-Sauné K; Marchou B; Massip P; Izopet J
J Clin Virol; 2010 Feb; 47(2):126-30. PubMed ID: 20015684
[TBL] [Abstract][Full Text] [Related]
20. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
